Not GMO: A new way to get CRISPR/Cas9 into plant cells without inserting foreign DNA
An NC State researcher has developed a new way to get CRISPR/Cas9 into plant cells without inserting foreign DNA. This allows for precise genetic deletions or replacements, without inserting foreign DNA. Therefore, the end product is not a genetically modified organism, or GMO.
CRISPR/Cas9 is a tool that can be used to precisely cut and remove or replace a specific genetic sequence. The Cas9 protein serves as a pair of molecular scissors, guided to the specific genetic target by an easily swapped RNA guide. Basically, it seeks out a specific genetic sequence and, when it finds that sequence, cuts it out. Once the target DNA is snipped, it can be deleted or replaced.
The CRISPR/Cas9 system has tremendous potential for improving crops by changing their genetic code. That does not necessarily mean inserting foreign DNA, but the systems used to deliver CRISPR/Cas9 into a plant’s cells often do, which means the relevant crop is a GMO. GMOs undergo through a rigorous evaluation process and many consumers prefer non-GMO products.
The U.S. Department of Agriculture (USDA) and the Food and Drug Administration regulate genetically engineered crops, and have standards defining what GMO crops are. These are focused on the presence of DNA sequences from other species being present in the end product.
Deleting or turning down a gene, such as the one responsible for turning sliced apples brown, does not introduce foreign DNA and thus is a non-GMO method. Similarly, altering the expression of a gene related to pest resistance in a variety of sweetpotato to make it more resistant, could be a non-GMO method.
In a new study published in the journal Plant Cell Reports, Wusheng Liu, a plant biologist and biotechnologist in the Department of Horticultural Science, demonstrated a new way of introducing the Cas9 protein and guide RNA into plant cells, which does not involve foreign DNA.
“This was the first time anyone has come up with a method to deliver the Cas9 protein through lipofection into plant cells,” Liu said. “Our major achievement was to make that happen. Also, since many consumers prefer non-GMO specialty crops, this method delivers the Cas9 protein in a non-GMO manner.”
Lipofection is a method that uses positively charged lipids, somewhat like those found in dish soap, to form a bubble-like liposome surrounding the Cas9/gRNA complex. The liposome binds to and then fuses with the plant cellular membrane, introducing its CRISPR cargo into the plant cell. It has been successfully used to deliver the CRISPR/Cas9 protein complex into mammalian cells.
“Many programs worldwide are focusing on CRISPR/Cas9 DNA delivery,” Liu said. “There’s only very limited amount of research focused on Cas9 protein delivery. But protein delivery has a lot of advantages.”
First of all, by delivering the Cas9 protein instead of the DNA sequence of Cas9, there is no transfer of specific DNA sequences from one species to another. The Cas9 protein lasts for three to five days and then is degraded. This reduces cutting at unwanted locations, called off-target cleavage, Liu said.
Also, the most common method of introducing DNA into plants is called Agrobacterium-mediated transformation. Agrobacterium is a group of bacteria that cause plant diseases. Scientists cannot control where the new DNA is added to the plant genome with this method, said Liu. Additionally, this method does not work for many elite varieties of crops which are very difficult to transform. Also, since the process introduces foreign DNA, the end product is a GMO.
On the other hand, the process of introducing CRISPR/Cas9 in a liposome requires that the tough, outer wall of the plant cell be removed. Plant cells without the cell wall are called protoplasts. Converting this protoplast into a shoot, and then a whole plant, requires a careful combination of plant hormones and nutrients. Methods for regenerating plants from protoplasts have been developed for more than 50 types of crops including wheat, tomatoes, strawberries and tobacco, said Liu. However, the methods have not been worked out for every crop.
Liu is also working on a few other methods of introducing the Cas9 protein into plant cells that do not require removing the cell wall.
One of these methods uses nanoparticles to introduce the Cas9 protein into pollen grains. Then, when the pollen is used to fertilize a female flower, the pollen tube will introduce Cas9 into the ovule along with the sperm. Some percentage of the resulting seed will have the desired genetic edits produced by the CRISPR/Cas9 complex. He would like to use this method to introduce Cas9 protein into tomato and hemp first, and eventually adapt them to other sexually reproduced crops, he said.
This research is funded by the USDA Agriculture and Food Research Initiative (AFRI) Agricultural Innovations through Genome Editing program.
Liu’s innovation has not gone unnoticed by his colleagues. Tom Ranney and Craig Yencho, professors within the Department of Horticultural Science, are among those who are collaborating with Liu to apply these non-GMO methods to advance beneficial traits in nursery crops and sweetpotatoes, respectively.
“Developing these systems for other specialty crops, including nursery crops and sweetpotatoes would be game changing,” Ranney said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- CRISPR Therapeutics's Options: A Look at What the Big Money is Thinking
Reflecting concerns, an analyst from JMP Securities lowers its rating to Market Outperform with a new price target of $74. Maintaining their stance, an analyst from Morgan Stanley continues to hold a ...
- CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular ...
- Buy Rating Reaffirmed for Crispr Therapeutics AG Amid Pipeline Expansion and Enhanced Treatment Efficacy
Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, ...
- CRISPR 2.0: a new wave of gene editors heads for clinical trials
Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.
- CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline
Based on early data from ongoing clinical studies, CRISPR (CRSP) has decided to focus on the development of its next-generation CAR T pipeline and discontinue its first-generation CAR T candidates.
Go deeper with Google Headlines on:
[google_news title=”” keyword=”CRISPR-Cas9″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- 13 Best Protein Powders by Type, According to Dietitians
Here’s our process. Healthline’s dietitians reviewed and chose the best protein powders by type. See the whey, plant, and organic picks that made our list. Whether you’re trying to lose ...
- Missing protein triggers alternative immune attack on cancer cells
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found certain immune cells can still fight cancer even when the cancer cells lack an important protein that the immune system relies on ...
- 38 High-Protein Breakfasts That Keep You Full
One way to ensure that you're feeling better and reaching your goals is to eat a high-protein breakfast in the morning. She also points out that protein takes longer to digest and therefore makes you ...
- What are lean protein sources?
Protein is an essential part of a balanced diet. People can get lean protein from animal sources, such as fish and low fat dairy, or from plant foods, such as lentils and legumes. The U.S. Departm ...
- CRISPR Gene Editing: Cas9 and Beyond
Johanna Pruller is a research associate at King’s College London where she previously obtained a PhD in molecular medicine and focused on the development of a gene therapy for alveolar... View full ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”Cas9 protein” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]